Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Antihypertensive Effect of Different Doses of ROSTAFUROXIN in Comparison With Losartan, Assessed by Office and Ambulatory Blood Pressure Monitoring in a Hypertensive Population Selected According to a Specific Genetic Profile.

X
Trial Profile

Antihypertensive Effect of Different Doses of ROSTAFUROXIN in Comparison With Losartan, Assessed by Office and Ambulatory Blood Pressure Monitoring in a Hypertensive Population Selected According to a Specific Genetic Profile.

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Apr 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rostafuroxin (Primary) ; Losartan
  • Indications Hypertension
  • Focus Pharmacogenomic; Therapeutic Use
  • Sponsors CVie Therapeutics; Windtree Therapeutics
  • Most Recent Events

    • 22 Dec 2015 According to a Lee's Pharmaceutical Holdings media release, enrollment has been completed in Italy in November 2015 and the first patient from Taiwan has been enrolled on 18 December 2015. The company expects to complete enrollment in Taiwan in June 2016.
    • 12 Jun 2013 Status changed from planning to recruiting, according to a Lee's Pharmaceutical Holdings media release. The first patient has been enrolled.
    • 13 Aug 2012 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top